Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO), has formed a new leadership team that will work instill a culture of excellence and dedication to customer service.
 
The following leaders and experts have been appointed to key management roles: Joseph Kiely as Chief Financial Officer, George Sanders as Vice President – Human Resources, Thomas Pamukcoglu as Vice President – Quality, James Drob as Head of Aseptic Manufacturing, John Phillips as Vice President – Sales, Bob Talley as General Counsel & Assistant Secretary, and Alexander Borodin as Senior Director of Supply Chain. In addition, Pii has promoted Devan Patel to Vice President – Client Services. Supporting Devan in his expanded role is Sara Frederick, who has joined Pii as Senior Director of Business Operations.
 
“I’m delighted to continue this journey of implementing real cultural change within the company. Among their responsibilities will be oversight of new operational processes and systems that will improve our ability to deliver on time and in full,” said Pii CEO John Fowler. “Every one of these new team leaders is an incredible addition to our company and an important piece of our company-wide strategy to provide best in class services to our partners.”
 
Joseph Kiely has more tha 30 years of experience in completing equity and debt financings for high growth, privately held life sciences companies. He has overseen multiple acquisitions and company dispositions while leading due diligence teams, negotiations and integrations. Most recently, he served as CFO and Head of Business Development at LSNE, Inc. and as EVP, CFO at Advion, Inc.
 
George Sanders recently held the same role at Getinge, a Swedish medical technology company. He has worked in many HR leadership roles in the medical technology space including Olympus and Thermo Fisher Scientific. He excels at implementing innovative talent acquisition initiatives, designing and executing successful integration of management talent among divisions and looks to promote a culture of fairness and equity.
 
Thomas Pamukcoglu is a highly seasoned quality executive within the pharma and biotech space. With a strong background in GMP and ISO Quality systems and operations, he has an extensive history of oversight in manufacturing sterile drugs, biologics, vaccines, medical devices, and commodities. Since 1987, he has served at many noted companies such as ICU Medical, Lonza, Astra Zeneca, SAFC Biosciences, and Abbott Laboratories.
 
James Drob is an established leader in the implementation of best practices to address regulatory, quality, technical and financial initiatives. His career highlights include management of aseptic filling lines – sterile injectables at Sanofi, as well as experience with Lantheus, the Lubrizol Corp., and ForDoz Pharma Corp.
 
John Phillips brings more than 27 years of direct business experience and excels in general management and P&L management across multiple roles. Committed to driving customer excellence, John previously served in business development leadership positions with BioDuro-Sundia, Thermo Fisher Scientific – Patheon, Sharp Packaging Solutions, and Mikart.
 
Devan Patel will oversee the company’s Business Operations & Program Management functions. He previously served as Pii’s Senior Director, Project Management, since 2012. In that position, Devan played a key role in Pii’s development and commercial programs for orals and injectables.
 
Sara Frederick, previously led a team of twenty-seven as Senior Director of Clinical Technology at WCG Clinical EndPoint Solutions. Prior to that, Sara held roles in project management and special projects at Piramal Pharma Solutions’ injectables site in Lexington, Kentucky.
 
Bob Talley is a highly experienced corporate executive. He previously served as President – Corporate, General Counsel & Secretary for Johnson Matthey North America, where he was a colleague of Pii CEO John Fowler. His career also includes positions as General Counsel in the manufacturing, advanced technologies, chemicals, and environmental controls industries. Bob’s skills span the gamut of business, corporate, employment, and transactional (M&A) law. Among his many other areas of expertise are risk management and organization development.
 
Alexander Borodin is an experienced supply chain professional. He previously worked at Catalent Pharma Solutions, where he developed and led the Gene Therapy Division S&OP process identifying several major planning, sourcing, and resource capacity bottlenecks and resolutions. He has also worked as an Online Adjunct Instructor at Colorado Technical University, teaching bachelor’s level Supply Chain and Project Management courses.